1.World Health Organization. Global tuberculosis control: WHO report 2017. Geneva, Switzerland World Health Organization; 2017. Available at: http://www.who.int/tb/publications/global_report/gtbr2017_main_text.pdf?ua = 1. Accessed Oct 31, 2017.
2.Marais BJ. Childhood tuberculosis: epidemiology and natural history of disease. Indian J Pediatr. 2011;78(3):321–7.
3.Marais BJ, Gie RP, Schaaf HS, Hesseling AC, Obihara CC, Starke JJ, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis. 2004;8(4):392–402.
4.Zar HJ, Pai M. Childhood tuberculosis - a new era. Paediatr Respir Rev. 2011;12(1):1–2.
5.Ayieko J, Abuogi L, Simchowitz B, Bukusi EA, Smith AH, Reingold A. Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta-analysis. BMC Infect Dis. 2014;14:91.
6.Mandalakas AM, Hesseling AC, Gie RP, Schaaf HS, Marais BJ, Sinanovic E. Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting. Thorax. 2013;68(3):247–55.
7.World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children. Geneva, Switzerland: WHO; 2006. Available at: http://whqlibdoc.who.int/hq/2006/WHO_HTM_TB_2006.371_eng.pdf. Accessed May 5, 2012.
8.World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children second edition. 2014. Available at http://apps.who.int/medicinedocs/documents/s21535en/s21535en.pdf. Accessed Dec 3, 2016.
9.World Health Organization. Global tuberculosis control: WHO report 2016. Geneva, Switzerland World Health Organization; 2016. Available at: http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf?ua = 1. Accessed Oct 31, 2016.
10.Starke JR. Mortality in childhood tuberculosis: has there been progress? Lancet Infect Dis. 2017;17(3):239–41.
11.Graham SM. The management of infection with Mycobacterium tuberculosis in young children post–2015: an opportunity to close the policy-practice gap. Expert Rev Respir Med. 2017;11(1):41–9.
12.Hill PC, Rutherford ME, Audas R, van Crevel R, Graham SM. Closing the policy-practice gap in the management of child contacts of tuberculosis cases in developing countries. PLoS Med. 2011;8(10):e1001105.
13.Szkwarko D, Hirsch-Moverman Y, Du Plessis L, Du Preez K, Carr C, Mandalakas AM. Child contact management in high tuberculosis burden countries: A mixed-methods systematic review. PLoS One. 2017;12(8):e0182185.
14.The World Bank. Mobile cellular subscriptions (per 100 people). Available from: https://data.worldbank.org/indicator/IT.CEL.SETS.P2. Accessed November 27, 2017.
15.U.S. Embassy in Lesotho. National Survey Shows Lesotho’s Remarkable Progress toward HIV Epidemic Control. Available at: https://ls.usembassy.gov/national-survey-shows-lesothos-remarkable-progress-toward-hiv-epidemic-control/. Accessed on Nov 10, 2017 [
16.Marais BJ, Rabie H, Cotton MF. TB and HIV in children - advances in prevention and management. Paediatr Respir Rev. 2011;12(1):39–45.
17.Dodd PJ, Gardiner E, Coghlan R, Seddon JA. Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study. Lancet Glob Health. 2014;2(8):e453–9.
18.Campbell JL, Quincy C, Osserman J, Pedersen OK. Coding In-depth Semistructured Interviews: Problems of Unitization and Intercoder Reliability and Agreement. Sociol Method Res. 2013;42(3):294–320.
19.Garrison DR, Cleveland-Innes M, Koole M, Kappelman J. Revisiting methodological issues in transcript analysis: Negotiated coding and reliability. The Internet and Higher Education. 2006;9:1–8. doi: 10.1016/j.iheduc.2005.11.001.
20.Dedoose Version 6.2.17, web application for managing, analyzing, and presenting qualitative and mixed method research data. Available from: www.dedoose.com. [Internet]. 2015 [
21.Assefa D, Klinkenberg E, Yosef G. Cross Sectional Study Evaluating Routine Contact Investigation in Addis Ababa, Ethiopia: A Missed Opportunity to Prevent Tuberculosis in Children. PLoS One. 2015;10(6):e0129135.
22.Rekha B, Jagarajamma K, Chandrasekaran V, Wares F, Sivanandham R, Swaminathan S. Improving screening and chemoprophylaxis among child contacts in India’s RNTCP: a pilot study. Int J Tuberc Lung Dis. 2013;17(2):163–8.
23.Rutherford ME, Ruslami R, Anselmo M, Alisjahbana B, Yulianti N, Sampurno H, et al. Management of children exposed to Mycobacterium tuberculosis: a public health evaluation in West Java, Indonesia. Bull World Health Organ. 2013;91(12):932–41A.
24.Rutherford ME, Ruslami R, Maharani W, Yulita I, Lovell S, Van Crevel R, et al. Adherence to isoniazid preventive therapy in Indonesian children: A quantitative and qualitative investigation. BMC Res Notes. 2012;5:7.
25.Tornee S, Kaewkungwal J, Fungladda W, Silachamroon U, Akarasewi P, Sunakorn P. Factors associated with the household contact screening adherence of tuberculosis patients. Southeast Asian J Trop Med Public Health. 2005;36(2):331–40.
26.Triasih R, Padmawati RS, Duke T, Robertson C, Sawyer SM, Graham SM. A mixed-methods evaluation of adherence to preventive treatment among child tuberculosis contacts in Indonesia. Int J Tuberc Lung Dis. 2016;20(8):1078–83.
27.Singh AR, Kharate A, Bhat P, Kokane AM, Bali S, Sahu S, et al. Isoniazid Preventive Therapy among Children Living with Tuberculosis Patients: Is It Working? A Mixed-Method Study from Bhopal, India. J Trop Pediatr. 2017.
28.Coprada L, Yoshimatsu S, Querri A, Lopez E, Agujo P, Paulino MR, et al. A review of tuberculosis contact investigations in the poor urban areas of Manila, The Philippines. Public Health Action. 2016;6(4):220–5.
29.Cruz AT, Ahmed A, Mandalakas AM, Starke JR. Treatment of Latent Tuberculosis Infection in Children. J Pediatric Infect Dis Soc. 2013;2(3):248–58.
30.Banu Rekha VV, Jagarajamma K, Wares F, Chandrasekaran V, Swaminathan S. Contact screening and chemoprophylaxis in India’s Revised Tuberculosis Control Programme: a situational analysis. Int J Tuberc Lung Dis. 2009;13(12):1507–12.
31.Skinner D, Hesseling AC, Francis C, Mandalakas AM. It’s hard work, but it’s worth it: the task of keeping children adherent to isoniazid preventive therapy. Public Health Action. 2013;3(3):191–8.